> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Johnson Memorial Hit with 483 After Inspection
- URL: https://www.fdaweb.com/johnson-memorial-hit-with-483-after-inspection/
- Published: 2022-01-31T12:00:00.000Z
- Updated: 2026-09-14T17:30:38.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151041

FDA has issued sterile drug product maker Johnson Memorial Cancer Center a Form FDA-483 after a 10/2021 inspection cited GMP deficiencies. For example, the [inspection observations](https://www.fda.gov/media/155773/download?ref=fdaweb.com) said the firm produced hazardous drugs without providing adequate cleaning of work surfaces to prevent cross-contamination. They also cited the company for not disinfecting materials/supplies prior to entering the aseptic processing areas, and it had inadequate HEPA filter coverage and airflow over the area to which sterile product was exposed.